Diagnostic Performance of Endosonography to Detect Mediastinal Lymph Node Metastasis in Patients with Radiological N1 Non-Small Cell Lung Cancer
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose Guidelines recommend that non–small cell lung cancer (NSCLC) patients with suspected hilar lymph node (LN) metastases should undergo invasive mediastinal LN staging prior to surgical treatment via endosonography. We evaluated the diagnostic performance of endosonography for detecting occult mediastinal metastases (OMM) and determined the factors associated with OMM in NSCLC patients with radiological N1. Materials and Methods Patients with confirmed primary NSCLC with radiological N1 who underwent endosonography for nodal staging assessment from January 2013 to December 2019 were retrospectively analyzed. Results The prevalence of OMM was found to be 83/279 (29.7%) and only 38.6% (32/83) were diagnosed via endosonography. However, five of them were confirmed as N3 by endosonography. The overall diagnostic sensitivity, negative predictive value, accuracy, and area under the curve of endosonography were 38.6%, 79.4%, 81.7%, and 0.69, respectively. In multivariable analysis, central tumor (adjusted odds ratio [aOR], 2.05; 95% confidence interval [CI], 1.15 to 3.68; p=0.016), solid tumor (aOR, 10.24; 95% CI, 1.32 to 79.49; p=0.026), and adenocarcinoma (aOR, 3.01; 95% CI, 1.63 to 5.55; p < 0.001) were related to OMM in radiological N1 NSCLC patients. Conclusion Although the sensitivity of endosonography for detecting OMM was only 40%, the prevalence of OMM was not low (30%) and some cases even turned out to be N3 diseases. Clinicians should be aware that OMM may be more likely in patients with central, solid, and adenocarcinomatous tumor when performing nodal staging in radiological N1 NSCLC via endosonography.
Abstract
Purpose Guidelines recommend that non–small cell lung cancer (NSCLC) patients with suspected hilar lymph node (LN) metastases should undergo invasive mediastinal LN staging prior to surgical treatment via endosonography. We evaluated the diagnostic performance of endosonography for detecting occult mediastinal metastases (OMM) and determined the factors associated with OMM in NSCLC patients with radiological N1. Materials and Methods Patients with confirmed primary NSCLC with radiological N1 who underwent endosonography for nodal staging assessment from January 2013 to December 2019 were retrospectively analyzed. Results The prevalence of OMM was found to be 83/279 (29.7%) and only 38.6% (32/83) were diagnosed via endosonography. However, five of them were confirmed as N3 by endosonography. The overall diagnostic sensitivity, negative predictive value, accuracy, and area under the curve of endosonography were 38.6%, 79.4%, 81.7%, and 0.69, respectively. In multivariable analysis, central tumor (adjusted odds ratio [aOR], 2.05; 95% confidence interval [CI], 1.15 to 3.68; p=0.016), solid tumor (aOR, 10.24; 95% CI, 1.32 to 79.49; p=0.026), and adenocarcinoma (aOR, 3.01; 95% CI, 1.63 to 5.55; p < 0.001) were related to OMM in radiological N1 NSCLC patients. Conclusion Although the sensitivity of endosonography for detecting OMM was only 40%, the prevalence of OMM was not low (30%) and some cases even turned out to be N3 diseases. Clinicians should be aware that OMM may be more likely in patients with central, solid, and adenocarcinomatous tumor when performing nodal staging in radiological N1 NSCLC via endosonography.
참고문헌 (28)
- De Leyn P, "Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer", Eur J Cardiothorac Surg, 45, pp.787~798 (2014)
- Vilmann P, "Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer : European Society of Gastrointestinal Endoscopy(ESGE)Guideline, in cooperation with the European Respiratory Society(ERS)and the European Society of Thoracic Surgeons(ESTS)", Endoscopy, 47, pp.c1~ (2015)
- "Non-small cell lung cancer, version 3.2022" (2022)[URL]
- Yasufuku K, "Endobronchial ultrasonography : current status and future directions", J Thorac Oncol, 2, pp.970~979 (2007)
- Ernst A, "Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer", J Thorac Oncol, 4, pp.947~950 (2009)
- Um SW, "Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer", J Thorac Oncol, 10, pp.331~337 (2015)
- Yasufuku K, "A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer", J Thorac Cardiovasc Surg, 142, pp.1393~1400 (2011)
- Tournoy KG, "Endoscopic ultrasound reduces surgical mediastinal staging in lung cancer : a randomized trial", Am J Respir Crit Care Med, 177, pp.531~535 (2008)
- Dooms C, "Endosonography for mediastinal nodal staging of clinical N1 non-small cell lung cancer : a prospective multicenter study", Chest, 147, pp.209~215 (2015)
- Leong TL, "Preoperative staging by EBUS in cN0", N1 lung cancer : systematic review and meta-analysis, 2019, pp.26, 155~165
- Shin SH, "The utility of endosonography for mediastinal staging of non-small cell lung cancer in patients with radiological N0 disease", Lung Cancer, 139, pp.151~156 (2020)
- Goldstraw P, "The IASLC Lung Cancer Staging Project : proposals for revision of the TNM stage groupings in the forthcoming 8th edition of the TNM classification for lung cancer", J Thorac Oncol, 11, pp.39~51 (2016)
- Giroux DJ, "The IASLC Lung Cancer Staging Project : data elements for the prospective project", J Thorac Oncol, 4, pp.679~683 (2009)
- Shin SH, "Which definition of a central tumour is more predictive of occult mediastinal metastasis in non-small cell lung cancer patients with radiological N0 disease?", Eur Respir J, 53, pp.1801508~ (2019)
- Wi S, "Clinical utility of EBUS-TBNA of hilar, interlobar, and lobar lymph nodes in patients with primary lung cancer", Thorac Cancer, 13, pp.2507~2514 (2022)
- Crombag LM, "Systematic and combined endosonographic staging of lung cancer(SCORE study)", Eur Respir J, 53, pp.1800800~ (2019)
- Lee HS, "Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer : how many aspirations per target lymph node station?", Chest, 134, pp.368~374 (2008)
- Kim HK, "Outcomes of mediastinoscopy and surgery with or without neoadjuvant therapy in patients with non-small cell lung cancer who are N2 negative on positron emission tomography and computed tomography", J Thorac Oncol, 6, pp.336~342 (2011)
- Watanabe S, "Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer", Ann Thorac Surg, 79, pp.1682~1685 (2005)
- Serra P, "Is it necessary to sample the contralateral nodal stations by EBUS-TBNA in patients with lung cancer and clinical N0", N1 on PET-CT?, 2020, pp.142, 9~12
- Cerfolio RJ, "Improving the inaccuracies of clinical staging of patients with NSCLC : a prospective trial", Ann Thorac Surg, 80, pp.1207~1213 (2005)
- Hishida T, "Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer", Thorax, 63, pp.526~531 (2008)
- El-Osta H, "Endobronchial ultrasound for nodal staging of patients with non-small-cell lung cancer with radiologically normal mediastinum : a meta-analysis", Ann Am Thorac Soc, 15, pp.864~874 (2018)
- Casal RF, "What exactly is a centrally located lung tumor? Results of an online survey", Ann Am Thorac Soc, 14, pp.118~123 (2017)
- Aokage K, "Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinoma", Eur J Cardiothorac Surg, 60, pp.64~71 (2021)
- Jianlong B, "Risk factors for lymph node metastasis and surgical scope in patients with cN0 non-small cell lung cancer : a single-center study in China", J Cardiothorac Surg, 16, pp.304~ (2021)
- Zhang Y, "A prediction model for N2 disease in T1 non-small cell lung cancer", J Thorac Cardiovasc Surg, 144, pp.1360~1364 (2012)
- Chen K, "Development and validation of a clinical prediction model for N2 lymph node metastasis in non-small cell lung cancer", Ann Thorac Surg, 96, pp.1761~1768 (2013)